Alzheimer’s Disease Tests
Alzheimer’s Point-of-Care Diagnostic
OPKO’s Alzheimer’s disease Point-of-Care diagnostic test is currently under development.
In April 2012, OPKO licensed intellectual property to Laboratory Corporation of America (LabCorp) for the development and commercialization of an Alzheimer’s disease diagnostic test in LDT (Laboratory Developed Test) format. LabCorp holds exclusive commercial rights to product marketing in both the United States and the United Arab Emirates.
Both test formats are based on OPKO’s proprietary molecular diagnostics platform.